CLINICAL_TRIALS
trial_result
· 2021-04-14
Clinical Trial Update: Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation [Phase 4]
Summary
Phase 4 trial update evaluating riluzole's effects on CNS glutamate and fatigue in breast cancer survivors with high inflammation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Inflammation, Fatigue | Phase 4 | Status: COMPLETED | Results posted: 2021-04-14